Content area
Abstract
Highlights
* A bivalent vaccine candidate was generated using reverse genetics techniques. * A recombinant NDV vector expressing the aMPV-C G protein was constructed. * The replication of the recombinant virus was maintainedin vitro, yet attenuatedin vivo. * Immunoresponses against aMPV-C and NDV were induced in vaccinated turkeys. * Complete protection against NDV and partial protection against aMPV-C was conferred.